Get started
ReversalJerk

MRNS Long

Long
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS)  
ReversalJerk Updated   
NASDAQ:MRNS   Marinus Pharmaceuticals, Inc.
Trend Analysis
2
0
trendanalysis
• Ticker - MRNS
• Entry: 2.30
• Stop loss: 1.92
• Profit target 1: 2.77
Comment:
Buy triggered - But risk:reward does not meet 2:1. If price action continues to look weak will cut.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.